These differences, combined together with the fact that we were able to demonstrate Sox9+ cells, but no Sox2 antigen reaction in the brain tissue around pCP, could be declared compatible with the varying growth behaviour of both tumour subtypes and a consequently different extent of reactive gliosis in the tumour surroundings. The gene discussed is SOX2; the disease is neoplasm.